BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17681085)

  • 1. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
    Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.
    Mannoury la Cour C; Salles MJ; Pasteau V; Millan MJ
    Mol Pharmacol; 2011 Jan; 79(1):91-105. PubMed ID: 20952497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
    Deslauriers J; Desmarais C; Sarret P; Grignon S
    J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.
    Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A
    Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol.
    Kimura M; Oda Y; Kimura H; Nangaku M; Hirose Y; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Pharmacol Biochem Behav; 2021 Mar; 202():173114. PubMed ID: 33485878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells.
    Park SW; Seo MK; Cho HY; Lee JG; Lee BJ; Seol W; Kim YH
    Neuropharmacology; 2011 Sep; 61(4):761-9. PubMed ID: 21663752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
    Khor TO; Gul YA; Ithnin H; Seow HF
    Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection.
    Ahn YM; Seo MS; Kim SH; Kim Y; Yoon SC; Juhnn YS; Kim YS
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):607-13. PubMed ID: 15877933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
    Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
    Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3.
    Sutton LP; Rushlow WJ
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):965-79. PubMed ID: 21777508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult.
    Kozlovsky N; Nadri C; Agam G
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):1-11. PubMed ID: 15572268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
    Zhao Z; Ksiezak-Reding H; Riggio S; Haroutunian V; Pasinetti GM
    Schizophr Res; 2006 May; 84(1):1-14. PubMed ID: 16581231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex.
    Kozlovsky N; Amar S; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2006 Jun; 9(3):337-42. PubMed ID: 16191209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
    Jensen J; Brennesvik EO; Lai YC; Shepherd PR
    Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental effects of early-life stress on dopamine D2 receptor and proteins involved in noncanonical D2 dopamine receptor signaling pathway in the prefrontal cortex of male rats.
    Mahmoodkhani M; Ghasemi M; Derafshpour L; Amini M; Mehranfard N
    J Complement Integr Med; 2022 Sep; 19(3):697-703. PubMed ID: 33962496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.
    Pandey GN; Rizavi HS; Tripathi M; Ren X
    Bipolar Disord; 2015 Mar; 17(2):160-71. PubMed ID: 25041379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.
    Pan B; Chen J; Lian J; Huang XF; Deng C
    PLoS One; 2015; 10(7):e0132722. PubMed ID: 26162083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
    Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
    J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex.
    Roh MS; Seo MS; Kim Y; Kim SH; Jeon WJ; Ahn YM; Kang UG; Juhnn YS; Kim YS
    Exp Mol Med; 2007 Jun; 39(3):353-60. PubMed ID: 17603289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.